Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
  1. 4 Grant or award Executive Chairman acquired 9,012 shares (grant or award)
  2. 4 Grant or award CEO & President acquired 38,857 shares (grant or award)
  3. 4 Grant or award EVP and CMO acquired 11,333 shares (grant or award)
  4. 4 Grant or award EVP and Chief Legal Officer acquired 9,068 shares (grant or award)
  5. 4 Grant or award EVP, Chief Technical Ops. Off. acquired 7,817 shares (grant or award)
  6. 4 Grant or award SVP & Chief Accounting Officer acquired 4,250 shares (grant or award)
  7. 4 Grant or award EVP, Chief Scientific Officer acquired 11,194 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale EVP, Chief Reg. & Quality Off. sold 4,500 shares at $474.99 ($2,137,455)
  11. 4 Planned sale EVP, CO & FO sold 9,532 shares at $461.00 ($4,394,252)
  12. 4 Planned sale EVP, CO & FO sold 14,000 shares at an average $456.00 ($6,384,000)
  13. 4 Planned sale EVP, Chief Reg. & Quality Off. sold 4,500 shares at $449.99 ($2,024,955)
  14. 4 Planned sale Executive Chairman sold 63,781 shares at an average $449.20 ($28,650,337)
  15. 4 Planned sale EVP and Chief Legal Officer sold 347 shares at $449.00 ($155,803)
  16. 4 Gift Director gave 800 shares (gift)
  17. 4 Planned sale EVP, Chief Technical Ops. Off. sold 2,500 shares at $434.58 ($1,086,450)
  18. 4 Planned sale Executive Chairman sold 73,292 shares at an average $440.60 ($32,292,320)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 129 · 2,568 filings